Efficacy and Safety of Addition of Empagliflozin in Diabetic Patients Uncontrolled With Glimepiride + Metformin + Teneligliptin

Abstract

BACKGROUNDThe aim of this study was to evaluate the efficacy and safety of empagliflozin as an add-on drug in type 2 diabetes mellitus (T2DM) patients demonstrating inadequate disease control to triple drug treatment of glimepiride, metformin and teneligliptin.